box ” warning describing the cardiovascular risks of stimulant drugs used to treat attention def-icit–hyperactivity disorder (ADHD). This action was unexpected, largely because the FDA had not requested a review of current la-beling for this class of drugs; it had merely asked for recommenda-tions of approaches to studying the cardiovascular risks associated with these drugs. The committee, however, decided to take an inde-pendent course. As a consultant to this committee, I introduced two motions, one recommending the black-box warning and the oth-er proposing the development of a guide for patients, which was approved by a vote of 15 to 0. The guides are handouts that are re-quired to be provided at the time prescriptions are dispensed; t...
attempted to draw up comprehensive clinical guidelines for the use of stimulant medications for atte...
Objective: A review of amphetamine treatment for attention-deficit/hyperactivity disorder (ADHD) was...
Methylphenidate was developed as a central nervous system (CNS) stimulant in the 1960s. It acts prim...
Last week, two separate advisory committees of the Food and Drug Administration assembled in the sub...
The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemp...
OBJECTIVE: In the last decades, several cognitive-enhancing drugs have been sold onto the drug marke...
Excerpt:The prognosis of attention deficit hyperactivity disorder (ADHA) continues to show heighten...
The use of performance enhancing drugs among athletes is something most people have become accustome...
BACKGROUND: Stimulant medications have been prescribed to effectively treat childhood Attention Defi...
Introduction: Methylphenidate is the first-line pharmacological treatment of attention-deficit/hyper...
The Author(s) 2010. This article is published with open access at Springerlink.com Abstract The safe...
The FDA committees and the manufacturers of the most common ADHD drugs have recently modified the pr...
The prognosis of attention deficit hyperactivity disorder (ADHD) continues to “show heightened risk ...
attempted to draw up comprehensive clinical guidelines for the use of stimulant medications for atte...
Although the prevalence of attention-deficit/hyperactivity disorder (ADHD) has been stable over the ...
attempted to draw up comprehensive clinical guidelines for the use of stimulant medications for atte...
Objective: A review of amphetamine treatment for attention-deficit/hyperactivity disorder (ADHD) was...
Methylphenidate was developed as a central nervous system (CNS) stimulant in the 1960s. It acts prim...
Last week, two separate advisory committees of the Food and Drug Administration assembled in the sub...
The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemp...
OBJECTIVE: In the last decades, several cognitive-enhancing drugs have been sold onto the drug marke...
Excerpt:The prognosis of attention deficit hyperactivity disorder (ADHA) continues to show heighten...
The use of performance enhancing drugs among athletes is something most people have become accustome...
BACKGROUND: Stimulant medications have been prescribed to effectively treat childhood Attention Defi...
Introduction: Methylphenidate is the first-line pharmacological treatment of attention-deficit/hyper...
The Author(s) 2010. This article is published with open access at Springerlink.com Abstract The safe...
The FDA committees and the manufacturers of the most common ADHD drugs have recently modified the pr...
The prognosis of attention deficit hyperactivity disorder (ADHD) continues to “show heightened risk ...
attempted to draw up comprehensive clinical guidelines for the use of stimulant medications for atte...
Although the prevalence of attention-deficit/hyperactivity disorder (ADHD) has been stable over the ...
attempted to draw up comprehensive clinical guidelines for the use of stimulant medications for atte...
Objective: A review of amphetamine treatment for attention-deficit/hyperactivity disorder (ADHD) was...
Methylphenidate was developed as a central nervous system (CNS) stimulant in the 1960s. It acts prim...